Literature DB >> 8866569

Epidermal growth factor induces glucose storage in transgenic 3T3-L1 adipocytes overexpressing epidermal growth factor receptors.

M Van Epps-Fung1, R W Hardy, J Williford, K Gupta, A Wells.   

Abstract

3T3-L1 adipocytes represent an established physiological model for studying glucose uptake and storage. Overexpression of epidermal growth factor (EGF) receptors in these cells (200,000-250,000 receptors per cell) confers EGF-inducible GLUT4-mediated glucose uptake (17). We now report that EGF receptor (EGFR)-mediated signals can induce incorporation of glucose into glycogen and lipids in these cells. Incorporation into lipids was stimulated to similar levels by insulin or EGF in adipocytes expressing full-length (wild type) EGFR (2.05 +/- 0.26-fold for insulin vs. 2.28 +/- 0.15-fold for EGF). EGF induced incorporation into glycogen at roughly 60% of the level of insulin (4.53 +/- 0.57-fold for insulin vs. 2.76 +/- 0.25-fold for EGF); this corresponded with similarly lower levels of glycogen synthase activation by EGF relative to insulin stimulation. EGFR kinase activity was required for induced storage because a kinase-inactive (M721) EGFR failed to stimulate glucose incorporation into glycogen or lipids. EGFRs that lack all or part of the unique EGFR COOH-terminal tail induced glucose incorporation at levels similar to that stimulated by full-length (wild type) EGFR. Thus, domains in the COOH-terminal tail of the EGFR, which are necessary for stimulating glucose transport, are not required for signaling EGF-induced glucose storage. EGF-induced glucose storage did not require de novo protein synthesis, suggesting that EGFR signaling uses existing pathways in the adipocytes. These data demonstrate that signaling pathways for EGFR-mediated glucose storage and GLUT4-mediated glucose transport diverge at the receptor level. Thus, EGF-induced glucose storage can be achieved in the absence of induced GLUT4-mediated glucose transport.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8866569     DOI: 10.2337/diab.45.11.1619

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  3 in total

Review 1.  Epidermal growth factor receptor expression escapes androgen regulation in prostate cancer: a potential molecular switch for tumour growth.

Authors:  A M Traish; A Morgentaler
Journal:  Br J Cancer       Date:  2009-11-03       Impact factor: 7.640

2.  Epiregulin as an Alternative Ligand for Leptin Receptor Alleviates Glucose Intolerance without Change in Obesity.

Authors:  No-Joon Song; Aejin Lee; Rumana Yasmeen; Qiwen Shen; Kefeng Yang; Shashi Bhushan Kumar; Danah Muhanna; Shanvanth Arnipalli; Sabrena F Noria; Bradley J Needleman; Jeffrey W Hazey; Dean J Mikami; Joana Ortega-Anaya; Rafael Jiménez-Flores; Jeremy Prokop; Ouliana Ziouzenkova
Journal:  Cells       Date:  2022-01-26       Impact factor: 6.600

3.  Beta Cell Mass Restoration in Alloxan-Diabetic Mice Treated with EGF and Gastrin.

Authors:  Imane Song; Oelfah Patel; Eddy Himpe; Christo J F Muller; Luc Bouwens
Journal:  PLoS One       Date:  2015-10-09       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.